Edition:
United States

Genovis AB (GENOb.ST)

GENOb.ST on Stockholm Stock Exchange

3.08SEK
22 May 2017
Change (% chg)

0.13kr (+4.41%)
Prev Close
2.95kr
Open
3.10kr
Day's High
3.10kr
Day's Low
2.92kr
Volume
54,825
Avg. Vol
55,906
52-wk High
3.84kr
52-wk Low
1.26kr

GENOb.ST

Chart for GENOb.ST

About

Genovis AB is a Sweden-based company engaged in the research and development, production and marketing of technologies and products for cellular research. The Company offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer,... (more)

Overall

Beta: 0.64
Market Cap(Mil.): kr177.87
Shares Outstanding(Mil.): 60.29
Dividend: --
Yield (%): --

Financials

  GENOb.ST Industry Sector
P/E (TTM): -- 31.06 17.37
EPS (TTM): -0.33 -- --
ROI: -159.69 12.87 -5.89
ROE: -160.89 15.33 -5.30

BRIEF-Genovis Q1 net sales up at SEK 4.8 million

* Q1 NET SALES SEK 4.8 MILLION VERSUS SEK 3.8 MILLION YEAR AGO

May 08 2017

BRIEF-Genovis carries out directed share issue with proceeds of SEK 11.5 mln

* GENOVIS CARRIES OUT DIRECTED SHARE ISSUE WITH PROCEEDS OF SEK 11.5 MILLION

Apr 10 2017

BRIEF-Genovis Q3 operating loss narrows to SEK 1.1 mln

* Q3 net sales 4.6 million Swedish crowns ($500,000) versus 3.4 million crowns year ago

Nov 23 2016

More From Around the Web

Earnings vs. Estimates